atai Life Sciences (ATAI) News Today $4.13 -0.02 (-0.48%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$4.14 +0.01 (+0.36%) As of 08/8/2025 07:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ATAI Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Maxim Group Reiterates a Buy Rating on Atai Life Sciences (ATAI) With a $10 PTAugust 4, 2025 | msn.comH.C. Wainwright Lifts PT on Atai Life Sciences (ATAI) to $15 From $10July 31, 2025 | msn.comATAI Life Sciences (ATAI) Gets a Buy from TD CowenJuly 30, 2025 | theglobeandmail.comOppenheimer Initiates Coverage of Atai Life Sciences N.V. (ATAI) with Outperform RecommendationJuly 30, 2025 | msn.comAtai: Inidascamine Trial Failure Doesn't Matter In Main Psychedelic Pipeline FocusJuly 28, 2025 | seekingalpha.comAtai backs away from schizophrenia drug after trial failureJuly 28, 2025 | finance.yahoo.comATAI Life Sciences (ATAI) Stock Plunge on Trial Failure NewsJuly 28, 2025 | finance.yahoo.comatai eyes 2025 catalysts in psychedelic portfolio following Recognify trial updateJuly 28, 2025 | proactiveinvestors.comATAI Life Sciences, Revvity And Other Big Stocks Moving Lower In Monday's Pre-Market SessionJuly 28, 2025 | benzinga.comRecognify’s Phase IIb trial of schizophrenia therapy fails to meet primary goalJuly 28, 2025 | finance.yahoo.comATAI Life Sciences stock falls after Recognify’s CIAS drug misses endpointJuly 26, 2025 | investing.comStocks to Watch: Atai Life Sciences, AmrepJuly 26, 2025 | marketwatch.comAtai Life Sciences' Stock Retreats After Recognify Schizophrenia Trial Misses EndpointJuly 26, 2025 | marketwatch.comAtai Life Sciences schizophrenia drug fails to meet main goal in trialJuly 26, 2025 | msn.comCanaccord Increases Atai Life Sciences (ATAI) PT, Keeps Buy RatingJuly 26, 2025 | insidermonkey.comAtai Life Sciences schizophrenia drug fails to meet main goal in mid-stage trialJuly 25, 2025 | reuters.comRecognify Life Sciences Provides Update on Phase 2b Trial of Inidascamine in Patients with Cognitive Impairment Associated with SchizophreniaJuly 25, 2025 | globenewswire.comatai Life Sciences poised to lead treatment-resistant depression market with psychedelic candidateJuly 23, 2025 | proactiveinvestors.comSpravato sales momentum underscores market potential for psychedelics, atai Life Sciences seen as key beneficiaryJuly 18, 2025 | proactiveinvestors.comAegis Capital Reaffirms Buy on Atai Life Sciences N.V. (ATAI) with $8 TargetJuly 11, 2025 | finance.yahoo.comCanaccord Genuity Lifts Atai Life Sciences N.V. (ATAI)’s Price Target To $12, Maintains Buy RatingJuly 9, 2025 | finance.yahoo.comRetail investors are Atai Life Sciences N.V.'s (NASDAQ:ATAI) biggest owners and were rewarded after market cap rose by US$121m last weekJuly 3, 2025 | uk.finance.yahoo.comatai Life Sciences and Beckley Psytech Announce Positive Topline Results from the Phase 2b Study of BPL-003 in Patients with Treatment-Resistant Depression - NasdaqJuly 2, 2025 | nasdaq.comatai Life Sciences price target boosted on robust BPL-003 mid-stage trial resultsJuly 2, 2025 | proactiveinvestors.comAtai: Critical Study Win Sets Up Double Approval Shot For Psychedelics In TRDJuly 2, 2025 | seekingalpha.comAtai and Beckley Psytech hail DMT trial results in treatment-resistant depressionJuly 2, 2025 | proactiveinvestors.comatai and Beckley Psytech’s psychedelic wins in Phase IIb depression trialJuly 1, 2025 | finance.yahoo.comAtai Shares Hit 2-Year High on Positive Trial Results, $50M FinancingJuly 1, 2025 | marketwatch.comAtai and Beckley, set to merge, reveal study success for psychedelic drugJuly 1, 2025 | finance.yahoo.comAtai Shares Rise on Beckley’s Psychedelic Drug Study SuccessJuly 1, 2025 | bloomberg.comAtai Life Sciences And Merger Partner Set Up Psychedelic Depression Therapy With Encouraging Late-Stage DataJuly 1, 2025 | benzinga.comATAI Life Sciences stock soars after positive Phase 2b depression drug resultsJuly 1, 2025 | in.investing.comAtai rises as psychedelic drug succeeds in mid-stage trial for depressionJuly 1, 2025 | msn.comATAI Life Sciences Shares Soar Following Strong Phase 2b Results for Depression TreatmentJuly 1, 2025 | msn.comatai Life Sciences Announces $50 Million Private Placement FinancingJuly 1, 2025 | globenewswire.comatai Life Sciences and Beckley Psytech Announce Positive Topline Results from the Phase 2b Study of BPL-003 in Patients with Treatment-Resistant DepressionJuly 1, 2025 | globenewswire.comATAI - ATAI Life Sciences NV Price vs Fair Value - MorningstarJune 27, 2025 | morningstar.comMATAI - ATAI Life Sciences NV Valuation - MorningstarJune 27, 2025 | morningstar.comMMaxim Group Maintains a Buy on Atai Life Sciences (ATAI) With a $6 Price TargetJune 24, 2025 | msn.comatai Life Sciences backed by positive sector readthrough from Compass Phase 3 data, analysts sayJune 23, 2025 | proactiveinvestors.comPsychedelics regain momentum in 2025 on political tailwinds, clinical winsJune 19, 2025 | proactiveinvestors.comFDA seen likely to grant emergency use authorizations for psychedelics, boosting sector stocksJune 18, 2025 | proactiveinvestors.comFDA seen likely to grant emergency use authorizations for psychedelics, boosting sector stocksJune 18, 2025 | proactiveinvestors.comHAPPY FATHER'S DAY! and $HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates the Merger of Atai Life Sciences N.V.June 15, 2025 | globenewswire.comATAI Stock Alert: Halper Sadeh LLC is Investigating Whether the Merger of Atai Life Sciences N.V. is Fair to ShareholdersJune 3, 2025 | businesswire.comAtai Life Sciences Stock Rockets On Merger Plans With Beckley Psytech; Retail Traders Eye Every DipJune 3, 2025 | msn.comATAI Life Sciences stock soars on Beckley Psytech merger dealJune 2, 2025 | investing.comATAI Life Sciences Shares Rise on Merger Deal with Beckley PsytechJune 2, 2025 | marketwatch.comATAI Life Sciences Shares Jump Following Merger Announcement with Beckley PsytechJune 2, 2025 | msn.comatai Life Sciences gains maximum exposure to key psychedelic asset with Beckley Psytech mergerJune 2, 2025 | proactiveinvestors.com Get atai Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ATAI and its competitors with MarketBeat's FREE daily newsletter. Email Address ATAI Media Mentions By Week ATAI Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ATAI News Sentiment▼0.000.46▲Average Medical News Sentiment ATAI News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ATAI Articles This Week▼13▲ATAI Articles Average Week Get atai Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ATAI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies MLTX News Today PTGX News Today AAPG News Today APLS News Today HCM News Today MOR News Today KYMR News Today IMVT News Today RARE News Today ALVO News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ATAI) was last updated on 8/9/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding atai Life Sciences N.V. Please log in to your account or sign up in order to add this asset to your watchlist. Share atai Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ATAI Stock Alerts